Mode
Text Size
Log in / Sign up

Eighteen assessment tools exist for identifying and managing stroke-related sarcopenia in clinical practiceNew tools help doctors measure muscle loss after a stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Select SRS assessment tools based on clinical context, such as HGS for strength or TMT for early screening.

This scoping review synthesizes the available evidence regarding assessment tools for stroke-related sarcopenia (SRS). The review identified 18 distinct assessment tools across 15 studies, categorized into four types: 8 anthropometric tools, 7 performance-based test tools, 1 questionnaire, and 2 calculation formulas.

Specific tools are highlighted for different clinical contexts. ALM/SMI is identified as the gold standard for muscle mass, while TMT allows for early screening via routine CT/MRI. For muscle strength, HGS is the preferred tool. Large-scale initial screening can be performed using CC and SARC-F. When instrumental measurement is unavailable, a validated ALM prediction formula serves as an alternative.

The review serves as a guide for healthcare professionals to select the most appropriate tool based on the specific clinical situation. However, the review identifies these tools for assessment purposes only and does not provide clinical trial data regarding the efficacy of these tools in improving patient outcomes. The findings are intended to assist in practical tool selection rather than establishing treatment efficacy.

How this fits prior evidence

This scoping review addresses a gap in the clinical management of stroke-related sarcopenia by identifying specific assessment tools. While prior coverage has addressed stroke risk factors, such as the lack of significant stroke risk increase following BNT162b2 vaccination, and management protocols like intra-arterial alteplase, this review focuses specifically on the diagnostic tools for sarcopenia. It provides a structured overview of 18 tools to assist in clinical selection.

After a stroke, many patients struggle with sarcopenia, which is the loss of muscle mass and strength. Identifying this loss early is vital for proper care, but doctors need reliable ways to measure it. A review of 15 studies identified 18 different tools to help healthcare teams assess this condition accurately.

These tools fall into several categories, including physical measurements, performance tests, and questionnaires. For example, some tools focus on muscle mass while others measure strength. For instance, the HGS is a preferred tool for measuring muscle strength, while TMT allows for early screening using standard imaging like CT or MRI scans.

Because every patient and clinic is different, having a variety of options is important. If high-tech equipment is not available, certain formulas can predict muscle mass. These findings help healthcare professionals pick the best tool based on what is available in their specific clinic to better monitor their patients.

What this means for you:
Doctors can use 18 different tools to measure muscle loss and strength in stroke patients.

Common questions

What tools are used to measure muscle loss after a stroke?

There are 18 different tools identified across 15 studies. These include 8 anthropometric tools, 7 performance-based test tools, 1 questionnaire, and 2 calculation formulas. These tools help doctors choose the best method based on what is available in their clinic.

Are there specific tools for measuring muscle strength?

Yes, the HGS is a preferred tool for measuring muscle strength in patients with stroke-related sarcopenia. Other tools, like the TMT, can be used for early screening using routine CT or MRI scans.

What happens if a clinic does not have advanced equipment?

If instrumental measurement is not available, a validated ALM prediction formula can be used as an alternative. This helps doctors assess muscle mass even when high-tech tools are missing.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundThe assessment of stroke-related sarcopenia (SRS) is not easy due to the paralysis and functional limitations in mobility after stroke. There is a need to identify tools for the assessment of SRS that stroke patients can complete. Objectives: This review aimed to summarize the tools that can be used to assess SRS.MethodsDatabases were systematically searched from the time of construction to 28 June 2026 based on the Arkensey and O’Malley framework. The databases searched included PubMed, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure, Wanfang, VIP and China Biomedical Literature Database.ResultsThis scoping review included 15 studies and identified 18 assessment tools, falling into four categories: 8 anthropometric tools, 7 performance-based test tools, 1 questionnaire, and 2 calculation formulas. ALM/SMI is the gold standard for muscle mass; TMT enables early screening via routine CT/MRI with no extra burden. HGS is preferred for muscle strength. CC and SARC-F suit large-scale initial screening. The validated ALM prediction formula provides an alternative when instrumental measurement is unavailable.ConclusionThe results of our study can help healthcare professionals to rationally select the appropriate and optimal SRS assessment tools according to the actual situation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.